46
Participants
Start Date
October 31, 2005
Primary Completion Date
June 30, 2017
Study Completion Date
December 30, 2017
temozolomide, thiotepa, carboplatin, 13-cis-retinoic acid
13-cis-retinoic acid, when absorbed, may be subject to first-pass metabolism and subsequent plasma (and tumor) concentrations will depend on the rate of metabolism to the inactive 4-oxo metabolite.
NYU Hassenfeld Center, New York
Steven and Alexandra Cohen Children's Medical Center of New York- North Shore LIJ, New Hyde Park
Roswell Park Cancer Institute, Buffalo
Children's Hospital of Philadelphia, Philadelphia
Virginia Commonwealth Univ., Richmond
Medical Univ. of South Carolina, Charleston
Emory University, Atlanta
Vanderbilt Univ., Nashville
Nationwide Children's Hospital, Columbus
Riley Hospital for Children, Indianapolis
Children's Hospital and Clinics of Minnesota, Minneapolis
Children's Memorial Hospital, Chicago
Children's Medical Center of Dallas, Dallas
MD Anderson Cancer Center (MDACC), Houston
Phoenix Children's Hospital, Phoenix
Hawaii Pacific Health, Lihue
Princess Margaret Hospital, Toronto
Children's Hospitals and Clinics of Minnesota
OTHER
Schneider Children's Hospital
OTHER
NYU Langone Health
OTHER